Publicaciones en las que colabora con José María Martínez Jabaloyas (3)

2013

  1. Anti-angiogenic therapies in prostate cancer

    Expert Opinion on Biological Therapy, Vol. 13, Núm. 1, pp. 1-5

2012

  1. Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics

    PLoS ONE, Vol. 7, Núm. 8

  2. Plasma hTERT mRNA discriminates between clinically localized and locally advanced disease and is a predictor of recurrence in prostate cancer patients

    Expert Opinion on Biological Therapy